Delivery Order SPE2DB20D2104-SPE2DB23FV28B
Award Date
9/11/23
Potential Completion Date
9/12/23
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of FYCOMPA 0.5 MG/ML oral suspension in 340 ML bottles to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, and has a ceiling value of $5,773.44. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award is for the delivery of FYCOMPA 6 MG TABLET 30S, a pharmaceutical product, to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,084.80 and a completion date of September 21, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract was awarded on September 20, 2023, and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML. The contract is a Delivery Order with a Firm Fixed Price of $2,903.46 and an Ultimate Completion Date of January 29, 2025. The contract is not designated as a Set-Aside. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award is for the delivery of FYCOMPA 4 MG TABLET 30S pharmaceutical products to the Defense Logistics Agency (DLA). The award, valued at $1,474.35, was issued on August 26, 2022 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., as the prime contractor. The contract has a performance period through August 29, 2022 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML. The contract has a ceiling value of $2,791.81 and a completion date of April 14, 2022. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,935.66, is for the delivery of FYCOMPA 0.5 mg/ml oral suspension (340 ml). The contract is a Firm Fixed Price Delivery Order with a completion date of February 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of FYCOMPA 4 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $1,731.08, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a period of performance through November 27, 2024 and was not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $6,767.54, is for the delivery of FYCOMPA 0.5 MG/ML oral suspension in 340 mL bottles. This is a firm-fixed price delivery order contract with a completion date of November 27, 2023. The contract is not associated with a set-aside and is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FN8A4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,688.40 firm fixed-price delivery order is for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a pharmaceutical product. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp, a major pharmaceutical...
This federal contract award is for the delivery of the prescription pharmaceutical product FYCOMPA 8 MG TABLET 30S to the Defense Logistics Agency (DLA), a defense agency. The $2,233.47 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of the major pharmaceutical distribution company Amerisourcebergen Corporation. The award represents a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to...